Taipei, April 15 (CNA) A panel of experts appointed by the Ministry of Health and Welfare (MOHW) has determined that a Taipei woman should receive NT$2.5 million (US$85,730) in compensation after suffering a blood-clotting disorder related to the AstraZeneca COVID-19 vaccine.
It was the highest sum ever awarded to an individual under the Vaccine Injury Compensation Program (VICP) due to symptoms induced by a COVID-19 vaccine that did not lead to death, the Central Epidemic Command Center (CECC) said Thursday.
The VICP panel convened on March 24 to review 45 cases involving individuals seeking compensation because of side effects from a COVID-19 vaccine, and decided that the claims in seven of the cases were valid, according to the CECC.
The woman who received the large award, a Taipei resident in her 40s surnamed Chen (陳), was hit by a headache, dizziness and fatigue 13 days after receiving the vaccine, according to a report released by the VICP panel earlier this week.
She was found to have low platelet levels and unusually high levels of D-dimer, a type of protein fragment, which signaled that her body was forming and breaking down blood clots, the report said.
The woman did not have any chronic ailments or any other conditions that could explain the rare blood-clotting disorder called “thrombosis with thrombocytopenia syndrome,” which is a known side effect of the AstraZeneca vaccine, leading the panel to conclude that the woman’s health issues were a direct result of the vaccine.
In the other six cases, two individuals received the Moderna vaccine and four people got the AstraZeneca vaccine.
The two Moderna vaccine takers received NT$5,000 and NT$500,000 in compensation, while the four individuals who received the AstraZeneca vaccine were awarded between NT$30,000 and NT$150,000 in compensation, the report said.